Cetera Investment Advisers
NUVB icon

Cetera Investment Advisers’s Nuvation Bio NUVB Stock Holding History

Cetera Investment Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Sell
29,714
-4,150
-12% -$23.1K ﹤0.01% 4397
2025
Q4 		$303K Buy
33,864
+13,460
+66% +$83.4K ﹤0.01% 3897
2025
Q3 		$75.5K Buy
20,404
+5,538
+37% +$15.1K ﹤0.01% 4376
2025
Q2 		$29K Buy
+14,866
New +$31K ﹤0.01% 4005

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Investment Advisers's NUVB Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Nuvation Bio (NUVB) stake by 12% in Q1 2026, selling an estimated $23.1K and leaving 29,714 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #4397.

Cetera Investment Advisers first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $303K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Cetera Investment Advisers held 29,714 shares of Nuvation Bio worth $127K as of Q1 2026.
  • Cetera Investment Advisers sold 4,150 Nuvation Bio shares in Q1 2026, an estimated $23.1K.
  • Nuvation Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4397 holding.
  • Cetera Investment Advisers first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Nuvation Bio position peaked at $303K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.